|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.76 USD | +7.97% |
|
+12.67% | -18.72% |
| 06-12 | Avalo Therapeutics' Lead Drug now a Cleaner Immunology Story, BofA Says | MT |
| 06-12 | BofA Initiates Avalo Therapeutics at Buy With $35 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bullish |
| Resistance | 16.16 | 16.16 | 21.57 |
| Spread/Res. | -8.66% | -8.66% | -31.57% |
| Spread/Supp. | +15.86% | +15.86% | +49.39% |
| Support | 12.74 | 12.74 | 9.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
